Harmen J G van de Werken Selected Research

Harmen J G van de Werken Research Topics

Disease

17	Neoplasms (Cancer) 03/2024 - 04/2015
4	Melanoma (Melanoma, Malignant) 12/2023 - 04/2015
3	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 11/2019
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
2	Bites and Stings (Sting) 12/2023 - 01/2022
2	Mesothelioma 12/2023 - 01/2023
2	Inflammation (Inflammations) 01/2023 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2019
1	Infections 02/2024
1	Chronic Hepatitis B 11/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2022
1	Atherosclerosis 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	COVID-19 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020
1	Anemia 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Hemolytic Anemia 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017
1	Carcinogenesis 01/2017
1	Hypertrophy 01/2016
1	Brugada Syndrome 04/2014

Drug/Important Bio-Agent (IBA)

7	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2018
4	Immune Checkpoint InhibitorsIBA 12/2023 - 12/2020
2	NucleosidesIBA 11/2023 - 03/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Androgen Receptors (Androgen Receptor)IBA 11/2022 - 11/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 12/2018
2	CateninsIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2019
1	Tenofovir (Viread)FDA Link 02/2024
1	entecavir FDA Link 02/2024
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2024
1	Peptides (Polypeptides)IBA 12/2023
1	cyclic diadenosine phosphateIBA 12/2023
1	OligodeoxyribonucleotidesIBA 12/2023
1	VaccinesIBA 12/2023
1	CopperIBA 03/2023
1	Protein Kinase InhibitorsIBA 03/2023
1	Adenosine Triphosphate (ATP)IBA 03/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	ibrutinibIBA 01/2023
1	AntigensIBA 01/2023
1	emt protein-tyrosine kinase (IL2-inducible T-cell kinase)IBA 01/2023
1	epidermal growth factor receptor VIIIIBA 12/2022
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	CholesterolIBA 01/2022
1	InterferonsIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	CytokinesIBA 01/2022
1	cabazitaxel FDA Link 11/2021
1	AndrogensIBA 11/2021
1	Axin ProteinIBA 01/2021
1	TankyrasesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 12/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 12/2018
1	Stem Cell FactorIBA 01/2018
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 01/2018
1	Nucleosomes (Nucleosome)IBA 01/2017
1	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 01/2017
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 01/2016
1	N-propionylprocainamideIBA 01/2016
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2015
1	Voltage-Gated Sodium ChannelsIBA 04/2014

Therapy/Procedure

6	Therapeutics 03/2024 - 12/2018
3	Immunotherapy 12/2023 - 01/2023
2	Castration 11/2022 - 11/2019
2	Nephroureterectomy 01/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 03/2023
1	Neoadjuvant Therapy 01/2017
1	Cystectomy 01/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Transurethral Resection of Bladder 01/2017